The Global Healthy Living Foundation (GHLF), parent non-profit of the CreakyJoints® online patient community, today announced ...
Disease-associated vision changes are common in GCA, with no significant difference in visual improvement observed with IV glucocorticoids vs oral therapy.
Ultrasound can be used as a first-line tool for regular and follow-up screening for aortic aneurysms in patients with giant cell arteritis due to a strong correlation with CT results, a study shows.
Topline data were announced from a phase 3 trial evaluating secukinumab in patients with polymyalgia rheumatica.
I rate AbbVie stock as a Strong Buy, based on its FDA approval of Rinvoq. Read the latest analysis on the stock here.
ABBV leans on booming Skyrizi and Rinvoq-driven sales to sustain growth and counter Humira's decline as Q3 results approach.
Pharmaceutical Technology on MSN
FDA approves AbbVie’s Rinvoq for inflammatory bowel disease
The FDA has approved AbbVie’s supplemental new drug application for Rinvoq (upadacitinib) to treat inflammatory bowel disease ...
MedPage Today on MSN
GLP-1 Drugs Tied to Lower Risk of Legal Blindness in People With Diabetes
ORLANDO -- Adding another twist to the ongoing debate about the effects of weight-loss drugs on vision, a retrospective ...
Celltrion launched its autoimmune disease treatment Avtozma (tocilizumab) in the US, the world’s largest pharmaceutical market, earlier this month, marking the ...
Merilyn Simonds, 76, started walking with Beth Robinson, 105, to find out what to expect as she got older. But the pair found ...
I read your recent column where you said that ivermectin has not been proven to be an effective treatment for cancer. I feel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results